Bregua Corporation
7
52M
5
0.29
1
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Bregua Corporation, startups are often financed by Avalon Ventures, Torrey Pines Investment, WuXi Healthcare Ventures. The meaningful sponsors for the fund in investment in the same round are Avalon Ventures, WuXi Healthcare Ventures, Vivo Capital.
Among the various public portfolio startups of the fund, we may underline Acousia Therapeutics, Fortis Therapeutics, Avelas Biosciences Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. The fund has exact preference in a number of founders of portfolio startups.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.29
- Investments by industry
- Biotechnology (7)
- Therapeutics (6)
- Health Care (2)
- Health Diagnostics (2)
- Pharmaceutical (2) Show 5 more
- Investments by region
-
- United States (6)
- Germany (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 135M
- Group Appearance index
- 1.00
- Avg. company exit year
- 4
- Avg. multiplicator
- 1.24
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Enlaza Therapeutics | 30 Apr 2024 | Biotechnology, Health Care, Therapeutics, Biopharma | Early Stage Venture | 100M | United States, California, La Jolla |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.